Rapporto sull’analisi delle dimensioni del mercato e delle quote degli agenti di embolizzazione | Previsioni 2031

  • Report Code : TIPRE00025058
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 219
Buy Now

Si prevede che il mercato degli agenti di embolizzazione raggiungerà i 4.525,75 milioni di dollari entro il 2028 rispetto ai 2.714,82 milioni di dollari del 2021; si prevede che crescerà a un CAGR del 7,6% dal 2021 al 2028.

La crescita del mercato è attribuita alla crescente incidenza di tumori e aneurismi e alla crescente prevalenza di ipertensione, obesità, fumo e alcolismo. Tuttavia, i costi elevati degli agenti di embolizzazione frenano la crescita del mercato degli agenti di embolizzazione. Gli agenti di embolizzazione vengono utilizzati per applicare un'occlusione meccanica per arrestare il flusso di sangue in un vaso sanguigno o in un'area vascolare. Nella radiologia interventistica, l’embolizzazione è una procedura comune. Le procedure di embolizzazione sono utilizzate principalmente per trattare lesioni traumatiche. Gli agenti embolici sono disponibili in una varietà di forme, ciascuna con il proprio insieme di proprietà e applicazioni. A seconda della durata richiesta per l'occlusione arteriosa, gli agenti di embolizzazione sono classificati come temporanei o permanenti.

Approfondimenti strategici
Negli Stati Uniti, la domanda di procedure di trattamento delle verruche si è ridotta a causa del cambiamento nel concentrarsi sul trattamento del COVID-19. La pandemia di COVID-19 ha causato il caos nelle catene di approvvigionamento, nei mercati di consumo e nelle economie globali. Questa situazione ha portato ad un calo degli interventi cardiaci eseguiti in vari paesi dell’Asia Pacifico. Le misure implementate dai governi di tutto il mondo hanno avuto un impatto negativo sulla crescita del mercato degli agenti di embolizzazione.

Regioni redditizie per il mercato degli agenti di embolizzazione



Approfondimenti di mercato
L'incidenza crescente di tumori e aneurismi alimenta la crescita del mercato degli agenti di embolizzazione
Secondo il National Cancer Institute, nel 2020, ci sono stati 1.806.590 nuovi casi di cancro e 606.520 decessi dovuti a la malattia negli Stati Uniti. Nel 2020, i tumori della prostata, del polmone e del colon-retto rappresentavano il 43% di tutti i tumori diagnosticati negli uomini. I tumori al seno, al polmone e al colon-retto sono i tre tumori più frequenti diagnosticati nelle donne. Secondo il rapporto Statistics and Facts della Brain Aneurysm Foundation, negli Stati Uniti, circa 6,5 milioni di persone, ovvero 1 persona su 50, hanno un aneurisma cerebrale non rotto. È stato anche menzionato che il 20% del totale delle persone a cui è stato diagnosticato un aneurisma cerebrale ha più di un aneurisma. È stato inoltre riferito che, ogni anno, circa 30.000 persone negli Stati Uniti soffrono di una rottura di aneurisma cerebrale e una rottura di aneurisma cerebrale avviene ogni 18 minuti. Inoltre, secondo il servizio sanitario nazionale, ogni anno nel Regno Unito, 1 persona su 12.500 ha una rottura di aneurisma cerebrale. Inoltre, secondo il progetto "Patogenesi degli aneurismi intracranici non rotti e gestione individualizzata" rapporto pubblicato su Deutsches Ärzteblatt International nel 2020, circa 2 milioni di persone (adulti) in Germania hanno un aneurisma intracranico (IA) non rotto. Gli agenti di embolizzazione vengono utilizzati per arrestare acutamente il flusso in un vaso sanguigno o in un territorio vascolare mediante occlusione meccanica. Gli agenti embolizzanti, come le microsfere emboliche (perline), vengono utilizzati per limitare l'apporto vascolare ai tumori e possono essere caricati con farmaci chemioterapici, che eluiscono e diffondono nel tessuto. Gli agenti embolici liquidi vengono utilizzati per impedire l'afflusso di sangue all'aneurisma o al tumore. Pertanto, la crescente prevalenza di aneurismi e tumori sta creando una forte domanda di agenti di embolizzazione.

Approfondimenti basati sul prodotto

In base al prodotto, il mercato degli agenti di embolizzazione è segmentato in bobine, sfere/particelle, tappi, palloncini staccabili, colla, spugna, embolici liquidi, sclerosanti, agenti precipitanti e altri. Il segmento delle perle/particelle detiene la quota maggiore del mercato. Tuttavia, si prevede che il segmento dei coil registrerà il CAGR più elevato nel periodo 2021-2028. L'embolizzazione con spirale è una procedura basata su catetere che consente l'occlusione precisa del flusso sanguigno anomalo in un vaso sanguigno. Il numero crescente di interventi di chirurgia cardiaca sta stimolando la crescita del mercato di questo segmento.

Mercato degli agenti di embolizzazione, per prodotto: 2021 e 2028



Approfondimenti basati sull'applicazione

In base all'applicazione, il mercato degli agenti di embolizzazione è segmentato in neurologia, oncologia, cardiologia, malattie vascolari periferiche e altri. Il segmento oncologico detiene la quota maggiore del mercato e si prevede che registrerà il CAGR più elevato sul mercato durante il periodo di previsione.

Approfondimenti basati sull'utente finale

Basati sull'utente finale, gli agenti di embolizzazione il mercato è segmentato in ospedali, centri chirurgici ambulatoriali, centri cardiaci e altri. Il segmento ospedaliero detiene la quota di mercato maggiore e si stima che registrerà il CAGR più elevato durante il periodo di previsione. La crescita del mercato per questo segmento è attribuita al crescente numero di ospedali in tutto il mondo e al rapido aumento del numero di procedure chirurgiche.

Le aziende che operano nel mercato degli agenti di embolizzazione stanno adottando la strategia di innovazione dei prodotti per soddisfare l'evoluzione richieste dei clienti in tutto il mondo, il che consente loro anche di mantenere il proprio marchio nel mercato globale.

Mercato degli agenti di embolizzazione: – per prodotto

  • Bobine
    • Bobine rimovibili
    • Bobine spingebili
  • Perline/Particelle
    • Sferico
    • Non sferico
  • Tappi
  • Palloncini staccabili
  • Colla
  • Spugna
  • Embolici liquidi
  • Sclerosanti
  • Agenti precipitanti
  • Altri

Mercato degli agenti di embolizzazione: per applicazione

  • Oncologia
  • Neurologia
  • Urologia
  • Cardiologia
  • Malattie vascolari periferiche
  • Altri

Mercato degli agenti di embolizzazione: per utente finale

  • Ospedali
  • Centri cardiaci
  • Centri chirurgici ambulatoriali
  • Altro
< h3>Mercato degli agenti di embolizzazione: per area geografica
  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • < li>Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
    • Resto dell'Europa
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
    • Resto dell'area APAC
  • Medio Oriente e Africa (MEA)
    • Sud Africa
    • Arabia Saudita
    • Emirati Arabi Uniti
    • Resto del MEA
  • America centrale e meridionale (SCAM )
    • Brasile
    • Argentina
    • Resto di SCAM

Profili aziendali

  • Medtronic
  • Terumo Corporation
  • Cook Medical LLC
  • Boston Scientific Corporation
  • Abbott
  • < li>Stryker Corporation
  • Penumbra, Inc.
  • Merit Medical Systems Inc.
  • DePuy Synthes
  • KANEKA CORPORATION
  • < /ul>
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are embolization agents?

Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are most used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration of time that arterial occlusion is required, embolization agents are classified as temporary or permanent.

What are the driving factors for the embolization agents market across the globe?

The factors that are driving growth of the market are rising incidence of tumors and aneurysms, and growing incidence of hypertension, obesity, smoking, and alcoholism.

Who are the developments carrying out by major players in the embolization agents market?

Various companies have made organic growth strategies in the embolization agents market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Medtronic, Cook Medical LLC amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which region is dominated the embolization agents market?

North America dominates the global embolization agents market due to factors such as increasing incidences of the neurological disorders such as stroke, brain aneurysms and others across the country, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

Which segment is growing at the highest CAGR in the embolization agents market?

The coil segment is growing at the highest CAGR owing to increasing number of cardiac surgeries.

Which region is the fastest growing in the embolization agents market?

Asia Pacific is expected to be the fastest growing region in the embolization agents market. The growth of the market in this region is primarily due to factors such as rising prevalence of the brain stroke, coronary artery diseases, heart diseases, increasing surgical procedures, growing number of hospitals and ambulatory surgeries centers, focus by industry players in Japan and developing healthcare infrastructure in India are likely to boost the market growth in forecast period.

The List of Companies - Embolization Agents Market

  1. Medtronic
  2. Terumo Corporation
  3. Cook Medical LLC
  4. Boston Scientific Corporation
  5. Abbott
  6. Stryker Corporation
  7. Penumbra, Inc.
  8. Merit Medical Systems Inc.
  9. DePuy Synthes
  10. KANEKA CORPORATION            

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports